Aggregation of a multidomain protein: A coagulation mechanism governs aggregation of a model IgG1 antibody under weak thermal stress

Using an IgG1 antibody as a model system, we have studied the mechanisms by which multidomain proteins aggregate at physiological pH when incubated at temperatures just below their lowest thermal transition. In this temperature interval, only minor changes to the protein conformation are observed. Light scattering consistently showed two coupled phases: an initial fast phase followed by several hours of exponential growth of the scattered intensity. This is the exact opposite of the lag‐time behavior typically observed in protein fibrillation. Dynamic light scattering showed the rapid formation of an aggregate species with a hydrodynamic radius of about 25 nm, which then increased in size throughout the experiment. Theoretical analysis of our light scattering data showed that the aggregate number density goes through a maximum in time providing compelling evidence for a coagulation mechanism in which aggregates fuse together. Both the analysis as well as size‐exclusion chromatography of incubated samples showed the actual increase in aggregate mass to be linear and reach saturation long before all molecules had been converted to aggregates. The CH2 domain is the only domain partly unfolded in the temperature interval studied, suggesting a pivotal role of this least stable domain in the aggregation process. Our results show that for multidomain proteins at temperatures below their thermal denaturation, transient unfolding of a single domain can prime the molecule for aggregation, and that the formation of large aggregates is driven by coagulation.

[1]  J. M. Sanchez-Ruiz.  Differential scanning calorimetry of proteins. , 1995, Sub-cellular biochemistry.

[2]  C. Rischel,et al.  The kinetic behavior of insulin fibrillation is determined by heterogeneous nucleation pathways , 2005, Protein science : a publication of the Protein Society.

[3]  Colleen E. Price,et al.  Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[4]  M. Matsumura,et al.  Elucidation of two major aggregation pathways in an IgG2 antibody. , 2009, Journal of pharmaceutical sciences.

[5]  B. Frisken,et al.  Revisiting the method of cumulants for the analysis of dynamic light-scattering data. , 2001, Applied optics.

[6]  Hervé Watier,et al.  From the bench to the bedside: ways to improve rituximab efficacy. , 2004, Blood.

[7]  Vincenzo Martorana,et al.  Protofibril Formation of Amyloid β-Protein at Low pH via a Non-cooperative Elongation Mechanism* , 2005, Journal of Biological Chemistry.

[8]  Christopher J Roberts,et al.  Non‐native protein aggregation kinetics , 2007, Biotechnology and bioengineering.

[9]  Vanni,et al.  Approximate Population Balance Equations for Aggregation-Breakage Processes. , 2000, Journal of colloid and interface science.

[10]  Joseph D. Kwasnoski,et al.  High-density miniaturized thermal shift assays as a general strategy for drug discovery. , 2001, Journal of biomolecular screening.

[11]  J. Feder,et al.  Heat aggregation kinetics of human IgG , 1985 .

[12]  G. Tiana,et al.  Kinetics of different processes in human insulin amyloid formation. , 2007, Journal of molecular biology.

[13]  Witten,et al.  Universal kinetics in reaction-limited aggregation. , 1987, Physical review letters.

[14]  Scott M Glaser,et al.  Antibody therapeutics, antibody engineering, and the merits of protein stability. , 2008, Current opinion in drug discovery & development.

[15]  Michael E. Fisher,et al.  Theory of Critical-Point Scattering and Correlations. I. The Ising Model , 1967 .

[16]  Jens Feder,et al.  Scaling behavior and cluster fractal dimension determined by light scattering from aggregating proteins , 1984 .

[17]  T. Hagiwara,et al.  Analysis of Aggregate Structure in Food Protein Gels with the Concept of Fractal. , 1997, Bioscience, biotechnology, and biochemistry.

[18]  V. Martorana,et al.  Protein stability modulated by a conformational effector: effects of trifluoroethanol on bovine serum albumin. , 2009, Physical chemistry chemical physics : PCCP.

[19]  Sandeep Nema,et al.  Protein Structural Conformation and Not Second Virial Coefficient Relates to Long-Term Irreversible Aggregation of a Monoclonal Antibody and Ovalbumin in Solution , 2006, Pharmaceutical Research.

[20]  C R Middaugh,et al.  Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability. , 2007, Journal of pharmaceutical sciences.

[21]  H. Tarko.  Theory of Critical-Point Scattering and Correlations. , 1974 .

[22]  J. Feder,et al.  Characterization of a heat-stable fraction of human IgG , 1986 .

[23]  Wim Jiskoot,et al.  Extrinsic Fluorescent Dyes as Tools for Protein Characterization , 2008, Pharmaceutical Research.

[24]  Hongcheng Liu,et al.  Heterogeneity of monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[25]  R. Bauer,et al.  Characterization and isolation of intermediates in beta-lactoglobulin heat aggregation at high pH. , 2000, Biophysical journal.

[26]  Huub Schellekens,et al.  Structural Characterization and Immunogenicity in Wild-Type and Immune Tolerant Mice of Degraded Recombinant Human Interferon Alpha2b , 2005, Pharmaceutical Research.

[27]  Garrett M. Morris,et al.  Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.

[28]  Sorensen,et al.  Variable aggregation rates in colloidal gold: Kernel homogeneity dependence on aggregant concentration. , 1990, Physical review. A, Atomic, molecular, and optical physics.

[29]  William F. Weiss,et al.  Characterization of high-molecular-weight nonnative aggregates and aggregation kinetics by size exclusion chromatography with inline multi-angle laser light scattering. , 2009, Journal of pharmaceutical sciences.

[30]  D. Kirschner,et al.  On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Hanns-Christian Mahler,et al.  Shaken, not stirred: mechanical stress testing of an IgG1 antibody. , 2008, Journal of pharmaceutical sciences.

[32]  Glyn L. Devlin,et al.  Protein particulates: another generic form of protein aggregation? , 2007, Biophysical journal.

[33]  E. Holborow,et al.  Intrinsically stable IgG aggregates. , 1981, Journal of immunological methods.

[34]  C. Dobson.  Protein folding and misfolding , 2003, Nature.

[35]  Roland Winter,et al.  Solvation-assisted pressure tuning of insulin fibrillation: from novel aggregation pathways to biotechnological applications. , 2006, Journal of molecular biology.

[36]  Hanns-Christian Mahler,et al.  Induction and analysis of aggregates in a liquid IgG1-antibody formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[37]  Wei Wang,et al.  Antibody structure, instability, and formulation. , 2007, Journal of pharmaceutical sciences.

[38]  D. Nohara,et al.  Kinetic study on thermal denaturation of hen egg-white lysozyme involving precipitation. , 1999, Journal of bioscience and bioengineering.

[39]  J. M. Sanchez-Ruiz,et al.  Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry. , 1992, Biophysical journal.

[40]  Ken A. Dill,et al.  Aggregation of globular proteins , 1993 .

[41]  D. Otzen,et al.  Amyloid—a state in many guises: Survival of the fittest fibril fold , 2007, Protein science : a publication of the Protein Society.

[42]  S. Demarest,et al.  A broad range of Fab stabilities within a host of therapeutic IgGs. , 2007, Biochemical and biophysical research communications.

[43]  J. L. López-Lacomba,et al.  Differential scanning calorimetry of the irreversible thermal denaturation of thermolysin. , 1988, Biochemistry.

[44]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[45]  J. García de la Torre,et al.  Calculation of hydrodynamic properties of globular proteins from their atomic-level structure. , 2000, Biophysical journal.

[46]  S. Yuba,et al.  Real-time and Single Fibril Observation of the Formation of Amyloid β Spherulitic Structures* , 2006, Journal of Biological Chemistry.

[47]  A. Vermeer,et al.  The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. , 2000, Biophysical journal.

[48]  John F. Carpenter,et al.  Physical Stability of Proteins in Aqueous Solution: Mechanism and Driving Forces in Nonnative Protein Aggregation , 2003, Pharmaceutical Research.

[49]  Anne S De Groot,et al.  Immunogenicity of protein therapeutics. , 2007, Trends in immunology.

[50]  Daniel E. Otzen,et al.  Protein drug stability: a formulation challenge , 2005, Nature Reviews Drug Discovery.

[51]  D. Durand,et al.  Kinetics of Aggregation and Gelation of Globular Proteins after Heat-Induced Denaturation , 1999 .

[52]  J. M. Sanchez-Ruiz,et al.  Lower kinetic limit to protein thermal stability: A proposal regarding protein stability in vivo and its relation with misfolding diseases , 2000, Proteins.

[53]  V. Martorana,et al.  Branching in amyloid fibril growth. , 2009, Biophysical journal.

[54]  D. Brems,et al.  Active dimer of Epratuzumab provides insight into the complex nature of an antibody aggregate. , 2006, Journal of pharmaceutical sciences.

[55]  F. Ferrone,et al.  Analysis of protein aggregation kinetics. , 1999, Methods in enzymology.

[56]  J. Carpenter,et al.  A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Durand,et al.  Structure and distribution of aggregates formed after heat-induced denaturation of globular proteins , 1994 .